A phase 2 study of vorinostat in acute myeloid leukemia
Background This two-stage, multi-institutional, randomized phase 2 trial assessed the toxicity and response rate associated with two treatment schedules of the histone deacetylase inhibitor, vorinostat (suberoylanilide hydroxamic acid; SAHA) in patients with relapsed acute myeloid leukemia and in se...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Ferrata Storti Foundation
2009-10-01
|
| Sarja: | Haematologica |
| Linkit: | https://haematologica.org/article/view/5373 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|